Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Thromb Res. 2019 Feb 13;177:59–69. doi: 10.1016/j.thromres.2019.01.017

Fig. 8.

Fig. 8.

Mechanism of PAR4/P2Y12 mediated αIIbβ3 and Rap1 activation and P-selectin expression. Schematic model of platelet activation upon prasugrel-mediated reduction in stent thrombosis through inhibition of dual thrombin receptors. Fast onset of inhibition of ADP signaling with the enhanced P2Y12 inhibitor prasugrel uncovered a new role for P2Y12/PAR4 in formation of more stable, growing platelet aggregates which contribute to both enhanced hemostasis and thrombosis.